Christopher Bowden - 22 Jun 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Christopher Bowden
Issuer symbol
TCRT
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 16:31:03 UTC
Previous filing
22 Jun 2021
Next filing
12 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +40,000 +960% $0.000000 44,167 22 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 22 Jun 2022 Common Stock 100,000 $0.8200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments beginning on July 13, 2022.